887 related articles for article (PubMed ID: 28745999)
21. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.
Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS
Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579
[TBL] [Abstract][Full Text] [Related]
22. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
[TBL] [Abstract][Full Text] [Related]
23. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
[TBL] [Abstract][Full Text] [Related]
24. Avacopan for the Treatment of ANCA-Associated Vasculitis.
Jayne DRW; Merkel PA; Schall TJ; Bekker P;
N Engl J Med; 2021 Feb; 384(7):599-609. PubMed ID: 33596356
[TBL] [Abstract][Full Text] [Related]
25. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
Hoffman GS; Cid MC; Rendt-Zagar KE; Merkel PA; Weyand CM; Stone JH; Salvarani C; Xu W; Visvanathan S; Rahman MU;
Ann Intern Med; 2007 May; 146(9):621-30. PubMed ID: 17470830
[TBL] [Abstract][Full Text] [Related]
26. Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.
Spiera R; Unizony SH; Bao M; Luder Y; Han J; Pavlov A; Stone JH
Semin Arthritis Rheum; 2021 Apr; 51(2):469-476. PubMed ID: 33784598
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial.
Venhoff N; Schmidt WA; Lamprecht P; Tony HP; App C; Sieder C; Legeler C; Jentzsch C; Thiel J
Trials; 2021 Aug; 22(1):543. PubMed ID: 34404463
[TBL] [Abstract][Full Text] [Related]
28. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
De Benedetti F; Brunner HI; Ruperto N; Kenwright A; Wright S; Calvo I; Cuttica R; Ravelli A; Schneider R; Woo P; Wouters C; Xavier R; Zemel L; Baildam E; Burgos-Vargas R; Dolezalova P; Garay SM; Merino R; Joos R; Grom A; Wulffraat N; Zuber Z; Zulian F; Lovell D; Martini A; ;
N Engl J Med; 2012 Dec; 367(25):2385-95. PubMed ID: 23252525
[TBL] [Abstract][Full Text] [Related]
29. Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study.
Christ L; Seitz L; Scholz G; Sarbu AC; Amsler J; Bütikofer L; Tappeiner C; Kollert F; Reichenbach S; Villiger PM
Lancet Rheumatol; 2021 Sep; 3(9):e619-e626. PubMed ID: 38287611
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A
Patel NJ; Tozzo V; Higgins JM; Stone JH
Arthritis Rheumatol; 2023 Apr; 75(4):586-594. PubMed ID: 36383175
[TBL] [Abstract][Full Text] [Related]
31. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME; Akuthota P; Jayne D; Khoury P; Klion A; Langford CA; Merkel PA; Moosig F; Specks U; Cid MC; Luqmani R; Brown J; Mallett S; Philipson R; Yancey SW; Steinfeld J; Weller PF; Gleich GJ;
N Engl J Med; 2017 May; 376(20):1921-1932. PubMed ID: 28514601
[TBL] [Abstract][Full Text] [Related]
32. A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis.
Schmidt WA; Dasgupta B; Sloane J; Giannelou A; Xu Y; Unizony SH; Mackie SL; Gonzalez-Gay MA; Spiera R; Warrington KJ; Villiger PM; Nivens MC; Akinlade B; Lin Y; Buttgereit F; Stone JH
Arthritis Res Ther; 2023 Oct; 25(1):199. PubMed ID: 37840134
[TBL] [Abstract][Full Text] [Related]
33. The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis.
Jogimahanti AV; Kini AT; Irwin LE; Lee AG
J Neuroophthalmol; 2021 Sep; 41(3):342-350. PubMed ID: 34415267
[TBL] [Abstract][Full Text] [Related]
34. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
35. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].
Broner J; Arnaud E
Rev Med Interne; 2018 Feb; 39(2):78-83. PubMed ID: 29221884
[TBL] [Abstract][Full Text] [Related]
37. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
Rosas IO; Bräu N; Waters M; Go RC; Hunter BD; Bhagani S; Skiest D; Aziz MS; Cooper N; Douglas IS; Savic S; Youngstein T; Del Sorbo L; Cubillo Gracian A; De La Zerda DJ; Ustianowski A; Bao M; Dimonaco S; Graham E; Matharu B; Spotswood H; Tsai L; Malhotra A
N Engl J Med; 2021 Apr; 384(16):1503-1516. PubMed ID: 33631066
[TBL] [Abstract][Full Text] [Related]
38. Design of the tocilizumab in giant cell arteritis trial.
Unizony SH; Dasgupta B; Fisheleva E; Rowell L; Schett G; Spiera R; Zwerina J; Harari O; Stone JH
Int J Rheumatol; 2013; 2013():912562. PubMed ID: 23653652
[TBL] [Abstract][Full Text] [Related]
39. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.
Langford CA; Cuthbertson D; Ytterberg SR; Khalidi N; Monach PA; Carette S; Seo P; Moreland LW; Weisman M; Koening CL; Sreih AG; Spiera R; McAlear CA; Warrington KJ; Pagnoux C; McKinnon K; Forbess LJ; Hoffman GS; Borchin R; Krischer JP; Merkel PA;
Arthritis Rheumatol; 2017 Apr; 69(4):837-845. PubMed ID: 28133925
[TBL] [Abstract][Full Text] [Related]
40. Tocilizumab for the treatment of giant cell arteritis.
Schirmer M; Muratore F; Salvarani C
Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
